CRIS Current Research Information System

BARBARA, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 519
EU - Europa 437
AS - Asia 208
AF - Africa 32
Totale 1.196
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 517
SE - Svezia 138
SG - Singapore 99
CN - Cina 79
IT - Italia 67
DE - Germania 62
IE - Irlanda 56
GB - Regno Unito 42
BG - Bulgaria 38
CI - Costa d'Avorio 19
CH - Svizzera 14
IN - India 14
TG - Togo 11
JO - Giordania 9
FI - Finlandia 7
IR - Iran 7
FR - Francia 6
CA - Canada 2
NL - Olanda 2
RO - Romania 2
LT - Lituania 1
NG - Nigeria 1
RU - Federazione Russa 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 1.196
Salva come PNG Salva come JPEG
Città #
Chandler 114
Singapore 80
Dublin 56
Ashburn 55
Princeton 48
Southend 38
Sofia 34
Berlin 22
Abidjan 19
Santa Clara 19
Bologna 15
Bern 14
Lomé 11
Milan 10
Amman 9
Guangzhou 9
Fairfield 6
Helsinki 6
Houston 6
New York 6
Turin 6
Washington 5
Frankfurt am Main 4
Los Angeles 4
Olalla 4
Shanghai 4
Wuhan 4
Cambridge 3
Chicago 3
Nuremberg 3
Perugia 3
Reggio Emilia 3
Seattle 3
Woodbridge 3
Amsterdam 2
Andover 2
Ann Arbor 2
Azzano San Paolo 2
Boardman 2
Boydton 2
Buffalo 2
Cedar Knolls 2
Cesenatico 2
Fuzhou 2
Hamburg 2
Jinan 2
Kunming 2
Kunshan 2
Leawood 2
Nottingham 2
Paris 2
Pellezzano 2
Piacenza 2
Prato 2
Prescot 2
Redmond 2
San Diego 2
Sant'Ilario d'Enza 2
Shenzhen 2
Taiyuan 2
Zanjan 2
Anyang 1
Augusta 1
Baia Mare 1
Baoding 1
Beijing 1
Büdelsdorf 1
Cesena 1
Chengdu 1
Council Bluffs 1
Des Moines 1
Dongying 1
Gaomi 1
Hangzhou 1
Harbin 1
Hebi 1
Henderson 1
Lagos 1
Lappeenranta 1
Lianyun 1
Montreal 1
Naples 1
Napoli 1
Pisa 1
Raleigh 1
San Lazzaro di Savena 1
Sebokeng 1
Shijiazhuang 1
Springfield 1
Suffern 1
Suzhou 1
Taizhou 1
Tianjin 1
Weifang 1
Winnipeg 1
Wuxi 1
Yunfu 1
Zhengzhou 1
Totale 720
Salva come PNG Salva come JPEG
Nome #
5-Aminosalicylic acid in patients with ulcerative colitis in remission: plasma levels after administration of a new rectal enema 91
5-Aminosalicylic acid suppositories in the management of ulcerative colitis 78
Cost-effectiveness analysis of the preparation of colonoscopy. Comparison between a PEG-electrolyte solution and a standard preparation 67
5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis? 64
Bioavailability of single and multiple doses of a new oral formulation of 5‐ASA in patients with inflammatory bowel disease and healthy volunteers 51
Changes in splanchnic hemodynamics in inflammatory bowel disease non-invasive assessment by doppler ultrasound flowmetry 48
Efficacy of 5-aminosalicylic acid enemas versus hydrocortisone enemas in ulcerative colitis 48
Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn's disease patients 44
Respiratory burst of circulating polymorphonuclear leukocytes and plasma elastase levels in patients with inflammatory bowel disease in remission 42
Macrophage subpopulations in pouchitis 42
Bronchopulmonary involvement in ulcerative colitis 42
Scavenger effect of sulphasalazine (SASP), 5-aminosalicylic acid (5-ASA), and olsalazine (OAZ) (I) 40
Role of rectal formulations: Enemas 39
Scavenger effect of sulfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation 38
Optimum dosage of 5-Aminosalicylic acid as rectal enemas in patients with active ulcerative colitis 37
Interleukin 1 in ulcerative colitis 36
Topical treatment with 5-aminosalicylic in distal ulcerative colitis by using a new suppository preparation - A double-blind placebo controlled trial 36
Requirements for the use of intestinal action antibiotics in the treatment of ulcerative colitis 36
Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease 33
Short report: zinc sulphate supplementation corrects abnormal erythrocyte membrane long‐chain fatty acid composition in patients with Crohn's disease 31
Steroid treatment in active Crohn's disease: a comparison between two regimens of different duration 28
Pentasa in maintenance treatment of ulcerative colitis 27
Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis 25
Mucosal concentrations of interleukin-1β, interleukin-6, interleukin-8, and tumor necrosis factor-α in pelvic ileal pouches 24
Rifaximin suspension for the eradication of helicobacter pylori 21
null 15
Effects of Dietary Fat on Postprandial Gastrointestinal Motility Are Inhibited by a Cholecystokinin Type A Receptor Antagonist 11
Familial adenomatous polyposis and inflammatory bowel disease associated in two kindreds 11
Rifaximin suspension for the eradication of helicobacter pylori 10
Endoscopic findings in 288 asymptomatic blood donors according to high levels of IgG to helicobacter pylori 9
Helicobacter pylori in Patients with Gastric and Nongastric Cancer 9
A clinical study of gastric emptying and bioadhesitivity of two forms of sucralfate 9
Detection of helicobacter pylori-like organisms in the stomach of some food-source animals using a monoclonal antibody 8
Gastric retention of sucralfate gel and suspension in upper gastrointestinal diseases 8
Clinical aspects of serology in the diagnosis of Helicobacter pylori infection 7
Endoscopic findings in 288 asymptomatic blood donors according to high levels of IgG to helicobacter pylori 7
Serological response to Helicobacter pylori in gastric and non-gastric cancer 7
Gastric retention of sucralfate gel and suspension in upper gastrointestinal diseases 6
A clinical study of gastric emptying and bioadhesitivity of two forms of sucralfate 6
Clinical aspects of serology in the diagnosis of Helicobacter pylori infection 6
Detection of helicobacter pylori-like organisms in the stomach of some food-source animals using a monoclonal antibody 5
Helicobacter pylori in Patients with Gastric and Nongastric Cancer 5
Source of Helicobacter pylori Infection 4
Biliary surgery without the surgeon! 4
Hypersensitivity of gastric parietal cells to selective H2-receptor stimulation in duodenal ulcer 4
The susceptibility of helicobacter pylori to the rifamycin, rifaximin 4
Helicobacter pylori and other spiral organisms in gastroduodenal disease 4
Comparison of urease tests for the diagnosis of Helicobacter pylori infection 4
Treatment of symptom-free Helicobacter pylori-positive subjects 4
Optimal nutritional indexes in gastroenterology 4
Peptic ulcer disease and Helicobacter pylori infection 4
Helibacter pylori and gastroduodenal disease 4
Serological response to Helicobacter pylori in gastric and non-gastric cancer 3
Comparison of urease tests for the diagnosis of Helicobacter pylori infection 3
Helicobacter pylori, diagnosis and treatment after 10 years of its discovery 3
Helicobacter pylori status, endoscopic findings, and serology in HIV-1-positive patients 3
Helicobacter pylori status, endoscopic findings, and serology in HIV-1-positive patients 3
Spectrotypic analysis of antibodies to Helicobacter pylori in patients with antral gastritis and duodenal ulcer 3
Circadian rhythm of gastric inhibitory polypeptide (GIP) in man 3
Spectrotypic analysis of antibodies to Helicobacter pylori in patients with antral gastritis and duodenal ulcer 2
Biliary surgery without the surgeon! 2
Helicobacter pylori, diagnosis and treatment after 10 years of its discovery 2
The susceptibility of helicobacter pylori to the rifamycin, rifaximin 2
Helibacter pylori and gastroduodenal disease 2
Peptic ulcer disease and Helicobacter pylori infection 2
Lactose Malabsorption in Adult Patients with Crohn's Disease 2
Helicobacter pylori and acid-related diseases of the stomach: mechanisms of pathogenesis 1
Screening for Helicobacter pylori 1
Pathogenic mechanisms of acid-related diseases: Helicobacter and other spiral organisms 1
Helicobacter pylori: its role in gastric disease 1
Prevalence of peptic ulcer in Helicobacter pylori positive blood donors 1
Prevalence of Helicobacter pylori in military barracks 1
Treatment of symptom-free Helicobacter pylori-positive subjects 1
Prevalence of Helicobacter pylori in military barracks 1
Prevalence of peptic ulcer in Helicobacter pylori positive blood donors 1
Serum pepsinogen I and II concentrations and IgG antibody to Helicobacter pyloni in dyspeptic patients 1
Helicobacter pylori and acid-related diseases of the stomach: mechanisms of pathogenesis 1
Helicobacter pylori and other spiral organisms in gastroduodenal disease 1
Serum pepsinogen I and II concentrations and IgG antibody to Helicobacter pyloni in dyspeptic patients 1
Pathogenic mechanisms of acid-related diseases: Helicobacter and other spiral organisms 1
Source of Helicobacter pylori Infection 1
Helicobacter pylori: its role in gastric disease 1
Totale 1.298
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.208
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.208
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 0 2 4 0 0 3
2021/2022258 0 1 1 4 2 1 1 2 81 33 100 32
2022/2023525 48 76 51 28 28 37 17 39 99 19 32 51
2023/2024270 73 33 23 24 21 49 6 22 3 13 3 0
2024/2025236 41 81 65 49 0 0 0 0 0 0 0 0
Totale 1.298